Previous close | 0.5750 |
Open | 0.5950 |
Bid | 0.5700 x 0 |
Ask | 0.5900 x 0 |
Day's range | 0.5600 - 0.6050 |
52-week range | 0.3000 - 0.7200 |
Volume | |
Avg. volume | 571,505 |
Market cap | 145.263M |
Beta (5Y monthly) | 1.24 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0300 |
Earnings date | 16 Feb 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
ADELAIDE, Australia, March 25, 2024--Archer Materials Limited ("Archer", the "Company", "ASX: AXE"), a semiconductor company advancing the quantum technology and medical diagnostics industries, has built a single chip integrated pulsed electron spin resonance ("p-ESR") microsystem, with its research partner École Polytechnique Fédérale de Lausanne ("EPFL") in Switzerland.
ADELAIDE, Australia, March 15, 2024--Archer Materials Limited ("Archer", the "Company", "ASX: AXE"), a semiconductor company advancing the quantum computing and medical diagnostics industries, has designed a miniaturised version of its Biochip graphene field effect transistor ("gFET") chip for fabrication at a commercial foundry.
While Archer Materials Limited ( ASX:AXE ) shareholders are probably generally happy, the stock hasn't had particularly...